- Home
- MSC vs WVE Comparison
MSC vs WVE Comparison
Compare MSC & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSC
- WVE
- Stock Information
- Founded
- MSC 2000
- WVE 2012
- Country
- MSC Hong Kong
- WVE Singapore
- Employees
- MSC N/A
- WVE N/A
- Industry
- MSC Hotels/Resorts
- WVE Biotechnology: Pharmaceutical Preparations
- Sector
- MSC Consumer Discretionary
- WVE Health Care
- Exchange
- MSC Nasdaq
- WVE Nasdaq
- Market Cap
- MSC 916.7M
- WVE 915.6M
- IPO Year
- MSC 2018
- WVE 2015
- Fundamental
- Price
- MSC $3.88
- WVE $6.97
- Analyst Decision
- MSC
- WVE Strong Buy
- Analyst Count
- MSC 0
- WVE 17
- Target Price
- MSC N/A
- WVE $19.94
- AVG Volume (30 Days)
- MSC 52.7K
- WVE 2.4M
- Earning Date
- MSC 11-04-2025
- WVE 11-11-2025
- Dividend Yield
- MSC N/A
- WVE N/A
- EPS Growth
- MSC N/A
- WVE N/A
- EPS
- MSC N/A
- WVE N/A
- Revenue
- MSC $679,264,000.00
- WVE $93,946,000.00
- Revenue This Year
- MSC $8.92
- WVE N/A
- Revenue Next Year
- MSC N/A
- WVE $10.02
- P/E Ratio
- MSC N/A
- WVE N/A
- Revenue Growth
- MSC 15.03
- WVE N/A
- 52 Week Low
- MSC $2.30
- WVE $5.28
- 52 Week High
- MSC $9.30
- WVE $16.74
- Technical
- Relative Strength Index (RSI)
- MSC 43.32
- WVE 29.71
- Support Level
- MSC $3.10
- WVE $7.12
- Resistance Level
- MSC $6.63
- WVE $7.76
- Average True Range (ATR)
- MSC 0.52
- WVE 0.50
- MACD
- MSC -0.05
- WVE -0.31
- Stochastic Oscillator
- MSC 22.10
- WVE 3.73
About MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.